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Abstract
Cancer cells migrating within a 3D microenvironment are able to adopt either a mesenchymal or amoeboid mode of
migration. Amoeboid migration is characterised by membrane blebbing that is dependent on the Rho effectors, ROCK1/2.
We identify LIMK2 as the preferred substrate for ROCK1 but find that LIMK2 did not induce membrane blebbing, suggesting
that a LIMK2 pathway is not involved in amoeboid-mode migration. In support of this hypothesis, novel FRET data
demonstrate a direct interaction between ROCK1 and LIMK2 in polarised but not blebbing cells. Our results point to a
specific role for the ROCK1:LIMK2 pathway in mesenchymal-mode migration.
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Introduction
Breast cancer metastasis depends on cell migration, a complex
process regulated spatially as well as temporally by the Rho family
GTPases Rho, Rac and Cdc42 [1]. These GTPases elicit a
response to extracellular signals on the actin cytoskeleton through
a variety of effector proteins. In a 3D microenvironment cancer
cells can adopt both mesenchymal and amoeboid like migratory
phenotypes [2]. Amoeboid migration is characterised by mem-
brane blebbing [3–5] a specialised form of cell protrusion that is
reversible and can occur during cell migration or during the
initiation of cytokinesis [6]. Membrane blebbing has been shown
to be induced by Rho effector protein ROCK [7] and amoeboid-
like movement is completely dependant on the interaction
between Rho and ROCK [2,5].
ROCK-1 and ROCK-2 are serine/threonine kinases which
have a number of cellular substrates including Myosin Light Chain
and LIM Kinase (LIMK) [8]. ROCK-dependent migration of
cancer cells is known to be driven by actomyosin contractions
[9,10]. However it is not known whether ROCK dependent
cancer cell amoeboid locomotion requires a ROCK: LIMK
interaction.
Activated LIMK proteins phosphorylate and inactivate the F-
actin severing protein, cofilin and this provides an alternative
mechanism for Rho-ROCK signalling to mediate its effects on the
F-actin cytoskeleton [11]. ROCK-LIMK signalling is thought to
promote retraction of neurites through regulation of cofilin activity
[12]. In addition, a role for ROCK and LIMK proteins in the
human epidermis has been identified [13]. The inhibition of cofilin
activity by ROCK-LIMK appears to be required for cell
compaction where a decrease in LIMK activity leads to an
increase in cofilin activity and a decrease in cell compaction [13].
An increase in ROCK levels has been detected in several
human cancers [14–16] and levels of LIMK-1 increase in invasive
and metastatic breast and prostate cell lines [17,18]. Therefore we
sought to better understand the contribution of a ROCK: LIMK
interaction to cancer cell migration by imaging the spatial
interaction between ROCK and LIMK in breast cancer cells
exhibiting both mesenchymal and amoeboid (blebbing) morphol-
ogies.
Materials and Methods
Antibodies and Reagents
Anti-ROCK1 was purchased from Transduction Laboratories,
Anti-LIMK2, anti-phospho-LIMK1/2 (Thr508/Thr505) from
Cell Signalling Technology. HRP-conjugated secondary antibod-
ies from DAKO and Alexa-phalloidin from Molecular Probes.
Expression plasmids encoding GFP, CFP, YFP and mRFP1
tagged LIMK1, LIMK2 and ROCK1 were generated using
Gateway
TM Technology (Invitrogen) and all plasmids were
sequenced. The ROCK inhibitor Y27632 was purchased from
Calbiochem.
Cell Culture
MDA-MB231 cells were grown in DMEM (Sigma) supple-
mented with 10% FBS (Helena Biosciences), L-glutamine and
100 U/ml penicillin-streptomycin. Cells were transiently trans-
fected using Lipofectamine 2000 transfection reagent according to
the manufacturers protocol (Invitrogen).
Phosphorylation assay
Cells were lysed into NP40 lysis buffer (1% v/v NP40; 50 mM
HEPES ph7.5; 0.5% w/v sodium deoxycholate; 150 mM NaCl;
1 mM EDTA). Samples were resolved by SDS-PAGE and
immunoblotted. Autoradiographs were scanned and quantitated
using Adobe software. Mean and s.e.m. values were calculated
from the data of 3 independent experiments.
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3398Figure 1. ROCK1 phosphorylates LIMK1 and LIMK2. A) and B) CFP-LIMK1 or 2 and either CFP-ROCK1 or CFP alone were transiently transfected
into MDA-MB231 cells and treated with 10 mM Y27632 for 24 hours. The resultant lysates were immunoblotted using anti-phospho-LIMK, -LIMK1, -
LIMK2 and -ROCK1 antibodies. (nsb=non-specific binding of the anti-ROCK1 antibody to a protein/s at 220 kDa). C) Ratio of phospho/total LIMK1
CFP-LIMK1 and D) Ratio of phospho/total LIMK2. (*=P,0.05).
doi:10.1371/journal.pone.0003398.g001
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Cells seeded on glass coverslips were fixed with 4% parafor-
maldehyde:PBS and permeabilised with 0.2% Triton X-100:PBS
as previously described [19]. Cells were then incubated with
TRITC-conjugated phalloidin for 1 h at room temperature.
Images of cells were obtained using a Zeiss LSM510 confocal
laser-scanning microscope (Welwyn Garden City, UK) and were
processed in Adobe Photoshop 7.0
TM. The Student paired t-test
was used to compare differences between groups. Statistical
significance was accepted for P#0.05
FRET: FLIM Microscopy
Cells were microinjected with the appropriate plasmids 24 hours
prior to fixing. The cells were then fixed as above and incubated with
fresh sodium borohydride (1 mg/ml in PBS) to quench background
fluorescence as previously described. FLIM was performed on a
Figure 2. ROCK1 but not LIMK2 induces blebbing. A) MDA-MB231 cells were transfected with GFP-ROCK1 or GFP-LIMK2, fixed and stained with
Alexa Fluor 594-Phalloidin and Dapi. 150 cells over 3 independent experiments were scored for visible blebbing+/2s.e.m. P,0.05; ***P,0.001. B)
Representative images from varying optical slices of a blebbing cell overexpressing GFP-ROCK1. (Bar=20 mm).
doi:10.1371/journal.pone.0003398.g002
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to calculate GFP lifetime and FRET efficiency was performed using
TRI2 software [19]. The number of pixels for each FRET efficiency
value were obtained from TRI2 and normalized by dividing it by the
sum of the pixels for that image. This normalized pixel count was
averaged over six cells per condition and then plotted against the
FRET efficiency to generate FRET efficiency histograms.
Results
ROCK1 phosphorylates LIMK1 and LIMK2 in breast cancer
cells
A number of laboratories have suggested that ROCK can
phosphorylate and activate LIMK1 and LIMK2 [20–26] and thus
we sought to establish if this is the same for MDA-MB231 cells. Pre-
Figure 3. ROCK1 and LIMK2 do not interact in blebbing cells. MDA-MB231 cells were microinjected with GFP-ROCK1 and mRFP-LIMK2, fixed,
imaged and analysed using FLIM microscopy and the TRI2 analysis programme. A) Images of the GFP lifetime and GFP and mRFP intensities across a
typical blebbing cell was displayed for a cell expressing both the GFP-ROCK1 donor and the mRFP-LIMK2 acceptor and for comparison, only the GFP -
ROCK1 donor. B) Histogram of the number of normalised pixel counts detected at each GFP lifetime. n=9.
doi:10.1371/journal.pone.0003398.g003
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PLoS ONE | www.plosone.org 4 October 2008 | Volume 3 | Issue 10 | e3398Figure 4. ROCK1 and LIMK2 interact in polarised cells. MDA-MB231 cells were microinjected with GFP-ROCK1 and mRFP-LIMK2, fixed, imaged
and analysed using FLIM microscopy and the TRI2 analysis programme. A) Images of the GFP lifetime and GFP and mRFP intensities across a typical
elongated cell was displayed for a cell expressing both the GFP-ROCK1 donor and the mRFP-LIMK2 acceptor and for comparison, only the GFP -
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LIMK2 phosphorylation in cells with endogenous and overex-
pressed CFP-ROCK1. In contrast, Y27632 reduces the ratio of
phospho to total LIMK1 in cells with overexpressed CFP-ROCK1
but not in those with endogenous levels of ROCK protein (Fig. 1).
Treatment of cellswith Y27632 induced a small decrease inLIMK1
and LIMK2 overexpression levels (Fig. 1A and B). However, whilst
LIMK2 phosphorylation is always sensitive to ROCK activity
LIMK1 phosphorylation is only sensitive to ROCK activity when
CFP-ROCK1 is overexpressed. Thus, our results demonstrate that
overexpression of ROCK1 alters the level of phosphorylation of
both LIMK1 and 2 but suggest that LIMK2 is the preferred
substrate of ROCK1 in these cells.
ROCK1 but not LIMK2 induces blebbing in breast cancer
cells
We found that whilst overexpression of GFP alone causes a small
but statistically significant increase in the number of blebbing cells
overexpression of GFP-ROCK1 induces a highly significant
increase in the percentage of blebbing cells (Fig. 2A and B).
Although not shown before in MDA-MB231 cells this has been
reported in other cell types [9,27–30]. In contrast overexpression of
GFP-LIMK2 did not induce a high level of membrane blebbing, we
also saw no indication of cell blebbing following overexpression of
LIMK1 (data not shown). In all cases blebbing cells had an intact
nucleus that did not fragment (Fig. 2A) indicating that this is not
membrane blebbing associated with apoptosis [31].
ROCK1 and LIMK2 do not interact in blebbing breast
cancer cells
Our results show that there is an interaction between ROCK1
and LIMK2 but suggest that this interaction is not involved in
membrane blebbing. We sought to confirm this hypothesis by
directly imaging the interaction between ROCK1 and LIMK2 in
blebbing and non-blebbing cells using FRET:FLIM microscopy.
This method not only allows an interaction between ROCK1 and
LIMK2 to be detected but also the localisation of such an
interaction to be determined spatially across the whole cell. In
order to compare the interaction of ROCK1 and LIMK2 in spread
and blebbing cells we used microinjection to moderate the level of
ROCK1 expression. Using this method the majority of cells, (63%),
exhibited a spread/polarised morphology, with smaller number of
blebbing cells (23%). In blebbing cells we detected no FRET
between GFP-ROCK-1 and mRFP-LIMK-2 (Fig. 3).
ROCK1 and LIMK2 interact in polarised breast cancer cells
Having established that ROCK1 and LIMK2 are not interacting
in blebbing cells we analysed the localisation and interaction of
ROCK1 and LIMK2 in spread cells. In spread cells the majority of
LIMK2 and ROCK expression is localised in cytoplasm, but
expression of both proteinscanbe detected inthenucleus(Fig. 4).In
MDA-MB231 cells with a spread/polarised phenotype we detected
a decreased GFP lifetime when ROCK1 and LIMK2 were co-
expressed, showing that ROCK1 and LIMK2 interact in spread
cells (Fig. 4). The GFP lifetime decrease is seen across the cell
cytoplasm in a punctate distribution. In comparison, two polarised
cells microinjected with only GFP-ROCK1 do not display any
decreaseinGFPlifetime(Fig.4).ThereisnosignificantdropinGFP
lifetime below control levels when cells expressing ROCK1 and
LIMK2arepre-incubatedwiththeROCKinhibitorY27632(Fig4).
Interestingly, in many cells there is a lack of any detectable
interaction between ROCK1 and LIMK2 at the cell periphery
(highlighted by arrowheads in Fig. 4).
Discussion
Previous studies had not identified whether a ROCK: LIMK
pathway contributed to the induction of membrane blebbing. We
provide here for the first time evidence of a direct and specific
interaction between ROCK1 and LIMK 2 in well-spread
mesenchymal cells which is absent in rounded blebbing cells.
Using FRET microscopy we found no interaction between
ROCK-1 and LIMK-2 in cells that displayed a membrane
blebbing phenotype, despite our own evidence that LIMK2 is the
preferred ROCK substrate in these cells. Our results suggest that a
ROCK1:LIMK2 interaction is not involved in the blebbing/
rounded phenotype and would not be required for amoeboid
migration. Indeed overexpression of LIMK2 does not induce
membrane blebbing in cells. Recent reports suggest that cellular
events downstream of ROCK activation are indeed separately
coordinated though MLC and cofilin phosphorylation [32].
In contrast our FRET studies identified a direct interaction
between ROCK1 and LIMK2 in concentrated foci in the
cytoplasm of cancer cells with a mesenchymal morphology. The
phosphorylation of LIMK-2 by ROCK-1 in the cell centre would
increase the level of phosphorylated cofilin, thereby decreasing F-
actin severing. This would stabilise the actomyosin filaments
present in cell body and promote the generation of the contractile
force necessary for tail retraction and cell migration [33]. Indeed,
it has previously been shown that TGF-induced actin stress fibre
formation is mediated by a ROCK-1/LIMK-2/cofilin pathway
[26]. Recently, a ROCK: LIMK1 pathway was implicated in the
co-ordination of cofilin activity at the plasma membrane of
invasive rat mammary carcinoma cells [34,35]. Our results point
to a distinct function for LIMK1 and LIMK2 downstream of
ROCK during breast cancer cell migration. We speculate that the
interaction between ROCK1 and LIMK2 does not play a
significant role in membrane blebbing associated cell migration
nor in the regulation of cofilin phosphorylation at the cell
periphery. Rather the interaction between ROCK1 and LIMK2
is restricted to the cell body of polarised well-spread cells where is
contributes to the stabilisation of actomyosin filaments and the
generation of contractile force through inactivation of cofilin.
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ROCK1 donor. B) Histogram of the number of normalised pixel counts detected at each GFP lifetime. C) A histogram of the average number of
normalised pixel counts detected at each GFP lifetime in cells expressing both GFP-ROCK1 donor and mRFP-LIMK2 acceptor in cells of elongated or
blebbing morphologies was constructed along with cells expressing only the GFP-ROCK1 donor. 18 cells over three independent experiments were
imaged for each time point. D) A Histogram of the number of normalised pixel counts detected at each GFP lifetime for cells expressing both GFP-
ROCK-1 donor and mRFP-LIMK-2 acceptor in MDA-MB231 cells pre-treated with Y27632. n=9.
doi:10.1371/journal.pone.0003398.g004
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